Proteomics

Dataset Information

0

Cardiac Amyloid Tissue Proteome


ABSTRACT: Cardiac AL and ATTR are potentially fatal cardiomyopathies. Current therapies do not address mechanisms of tissue dysfunction, mostly because these remain unknown. Our prior work has focused on the amyloid plaque proteome, which may not capture tissue-wide proteomic alterations. In this study, we used a bulk (entire biopsy) tissue proteomics approach to evaluate mechanisms of tissue dysfunction in cardiac AL/ATTR. We included 76 ATTR cases and 27 AL cases. In stage 3 AL patients, pathways involved in coagulation, extracellular matrix (ECM) remodeling, epithelial-to-mesenchymal transition (EMT), complement activation, hypoxia and clathrin-mediated endocytosis were increased compared to stage 1/2,whereas pathways involved in healthy cardiac metabolism and proteostasis were decreased. In Mayo stage 2/3 ATTR, immunoglobulin proteins, complement and keratin pathways were increased compared to stage 1. Principal component analyses identified an ATTR group with worse survival independent of existing staging systems that also showed upregulation of complement and downregulation of oxidative phosphorylation pathways. Finally, when comparing AL with ATTR, complement proteins were increased in ATTR whereas clathrin-mediated endocytosis , mRNA splicing, spliceosome pathways and ribosomal proteins were increased in AL. Clathrin-mediated endocytosis has been implicated in Aβ amyloid clearance by non-immune cells in the setting of Alzheimer’s disease and could represent a proteostatic mechanism of cardiomyocytes in response to AL fibrils. Impaired spliceosome and translation machinery has been associated with cardiac ECM-R in other cardiomyopathies. Our results support an immune-mediated mechanism of tissue toxicity in cardiac amyloidosis including activation of the complement cascade, especially among ATTR patients with worse outcomes.

INSTRUMENT(S): maXis

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Heart

SUBMITTER: Surendra Dasari  

LAB HEAD: Surendra Dasari

PROVIDER: PXD058715 | Pride | 2025-01-15

REPOSITORIES: pride

Dataset's files

Source:
Action DRS
P23001_158samp_kj6_Report_2.xls.xlsx Xlsx
P23001_230412_06_T050_BA1_1_4105.d.tar Other
P23001_230412_08_T051_BA2_1_4107.d.tar Other
P23001_230412_10_L005_BA3_1_4109.d.tar Other
P23001_230412_12_T067_BA4_1_4111.d.tar Other
Items per page:
1 - 5 of 116
altmetric image

Publications

Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage.

Netzel Brian C BC   Charlesworth M Cristine MC   Johnson Kenneth L KL   French Amy J AJ   Dispenzieri Angela A   Maleszewski Joseph J JJ   McPhail Ellen D ED   Grogan Martha M   Redfield Margaret M MM   Weivoda Megan M   Muchtar Eli E   Gertz Morie A MA   Kumar Shaji K SK   Misra Pinaki P   Vrana Julie J   Theis Jason J   Hayman Suzanne R SR   Ramirez-Alvarado Marina M   Dasari Surendra S   Kourelis Taxiarchis T  

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 20250108 1


<h4>Background</h4>Cardiac AL and ATTR are potentially fatal cardiomyopathies. Current therapies do not address mechanisms of tissue dysfunction because these remain unknown. Our prior work focused on the amyloid plaque proteome, which may not capture tissue-wide proteomic alterations.<h4>Objectives</h4>To evaluate mechanisms of tissue dysfunction in cardiac AL and ATTR using a full biopsy tissue proteomics approach.<h4>Methods</h4>We performed proteomics analysis on 76 ATTR and 27 AL diagnostic  ...[more]

Similar Datasets

2012-12-01 | E-GEOD-39954 | biostudies-arrayexpress
2021-07-19 | GSE172295 | GEO
2012-12-01 | GSE39954 | GEO
2021-07-14 | GSE133330 | GEO
2013-08-30 | E-GEOD-49699 | biostudies-arrayexpress
2013-08-30 | GSE49699 | GEO
2015-05-12 | GSE49036 | GEO
2023-12-07 | PXD045068 | Pride
2015-01-01 | E-GEOD-58316 | biostudies-arrayexpress
2017-02-09 | GSE81088 | GEO